Cellix Ltd logo

Cellix Ltd

Contact Details

Skip to Navigation |  Skip to Content |  Skip to Login
Start of page content

Cardiovascular

Eliminates false leads earlier through continuous flow cell based assays
Cellix's solution enables continuous whole blood flow to be monitored in real-time.  The advantages of the Cellix platform and biochips are that only microlitre volumes of whole blood are required for studies combined with live-cell imaging of whole blood interactions with endothelial cells. Cellix have validated this technology in the following areas: Thrombosis, Atherosclerosis and Stents.
 
Atherosclerosis Thrombosis Stents

 

 

alt

alt

 alt
 

Register/Login

Not Registered? Sign Up Now

Register for My Cellix

Bottom Navigation